IL198856A0 - Compounds useful for treating neurodegenerative disorders - Google Patents

Compounds useful for treating neurodegenerative disorders

Info

Publication number
IL198856A0
IL198856A0 IL198856A IL19885609A IL198856A0 IL 198856 A0 IL198856 A0 IL 198856A0 IL 198856 A IL198856 A IL 198856A IL 19885609 A IL19885609 A IL 19885609A IL 198856 A0 IL198856 A0 IL 198856A0
Authority
IL
Israel
Prior art keywords
compounds useful
neurodegenerative disorders
treating neurodegenerative
treating
disorders
Prior art date
Application number
IL198856A
Original Assignee
Satori Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Satori Pharmaceuticals Inc filed Critical Satori Pharmaceuticals Inc
Publication of IL198856A0 publication Critical patent/IL198856A0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D335/00Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/34Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
    • A01N43/40Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
    • A01N43/42Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings condensed with carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/12Ophthalmic agents for cataracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Ophthalmology & Optometry (AREA)
  • Psychology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Endocrinology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)
IL198856A 2006-11-20 2009-05-20 Compounds useful for treating neurodegenerative disorders IL198856A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2006/044880 WO2008063165A1 (en) 2006-11-20 2006-11-20 Compounds useful for treating neurodegenerative disorders

Publications (1)

Publication Number Publication Date
IL198856A0 true IL198856A0 (en) 2010-02-17

Family

ID=39429980

Family Applications (1)

Application Number Title Priority Date Filing Date
IL198856A IL198856A0 (en) 2006-11-20 2009-05-20 Compounds useful for treating neurodegenerative disorders

Country Status (10)

Country Link
EP (1) EP2073637A4 (en)
JP (1) JP2010510309A (en)
KR (1) KR20090087075A (en)
CN (1) CN101610673A (en)
AU (1) AU2006350960B2 (en)
BR (1) BRPI0622138A2 (en)
CA (1) CA2670276A1 (en)
IL (1) IL198856A0 (en)
MX (1) MX2009005351A (en)
WO (1) WO2008063165A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI433674B (en) 2006-12-28 2014-04-11 Infinity Discovery Inc Cyclopamine analogs
US7990394B2 (en) 2007-05-25 2011-08-02 Google Inc. Viewing and navigating within panoramic images, and applications thereof
ES2567134T3 (en) 2009-08-05 2016-04-20 Infinity Pharmaceuticals, Inc. Enzymatic transamination of cyclopamine analogs
US9394313B2 (en) 2010-09-14 2016-07-19 Infinity Pharmaceuticals, Inc. Transfer hydrogenation of cyclopamine analogs
JP6796638B2 (en) 2015-06-04 2020-12-09 ペレファーム, インク.Pellepharm, Inc. Topical formulations and their use for the delivery of hedgehog inhibitory compounds
US10217283B2 (en) 2015-12-17 2019-02-26 Google Llc Navigation through multidimensional images spaces
US10245091B2 (en) 2015-12-30 2019-04-02 Exsomed Holding Company, Llc Dip fusion spike screw
CN107281206A (en) * 2016-03-30 2017-10-24 南京惠宝生物医药有限公司 Black cohosh root glycosides is preparing the application in preventing and treating senile dementia medicine
KR102120376B1 (en) * 2018-05-28 2020-06-09 한국과학기술연구원 Composition for preventing and/or treating a degenerative brain disease comprising as an active ingredient an extract of Cimicifuga dahurica, a fraction thereof, or a compound derived from Cimicifuga dahurica
CN109528738A (en) * 2018-12-24 2019-03-29 陕西师范大学 Glycyrrhizic acid promotes the application of Remyelination inhibition neuroinflamation drug in preparation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030060425A1 (en) * 1998-11-24 2003-03-27 Ahlem Clarence N. Immune modulation method using steroid compounds
GB9923077D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
AU2003218180B2 (en) * 2002-03-15 2008-03-20 Georgetown University Neuroprotective spirostenol pharmaceutical compositions
US7851641B2 (en) * 2005-05-17 2010-12-14 Satori Pharmaceuticals, Inc. Compounds useful for treating neurodegenerative disorders

Also Published As

Publication number Publication date
EP2073637A4 (en) 2011-12-28
CA2670276A1 (en) 2008-05-29
CN101610673A (en) 2009-12-23
JP2010510309A (en) 2010-04-02
EP2073637A1 (en) 2009-07-01
KR20090087075A (en) 2009-08-14
BRPI0622138A2 (en) 2011-12-27
AU2006350960A1 (en) 2008-05-29
WO2008063165A1 (en) 2008-05-29
AU2006350960B2 (en) 2013-09-12
MX2009005351A (en) 2009-06-08

Similar Documents

Publication Publication Date Title
EP2083857A4 (en) Methods for treating mica-related disorders
HK1225620A1 (en) Complement inhibition for improved nerve regeneration
IL198856A0 (en) Compounds useful for treating neurodegenerative disorders
IL194739A0 (en) Dihydrothienopyrimidine for treating inflammatory disorders
AP2009004746A0 (en) Process for prepaiIrng diaminophenothiazinium compounds
ZA200809528B (en) Treatment for depressive disorders
AU2007288337A8 (en) Compounds for treating proliferative disorders
ZA200806074B (en) Compounds for the treatment of inflammatory disorders
IL198851A0 (en) Methods for treating hypercholesterolemia
ZA200900734B (en) Combination treatment for metabolic disorders
IL184456A0 (en) Dosage form for treating gastrointestinal disorders
IL209895A0 (en) Compounds for treating beta-amyloidoses
ZA200809527B (en) Treatment for depressive disorders
IL187439A0 (en) Compounds useful for treating neurodegenerative disorders
PL1993589T3 (en) Treatments for neurological disorders
IL188729A0 (en) Carbamate compounds for use in treating neurodegenerative disorders
PL1841433T3 (en) Composition for treating central nervous system disorders
EP2331097A4 (en) Methods for treating cns disorders
IL194373A0 (en) Methods for treating kidney disorders
IL207906A0 (en) Treatment for ocular-related disorders
IL188127A0 (en) Methods for treating demyelination disorders
ZA200901672B (en) Compounds for treating proliferative disorders
ZA200807678B (en) Meridamycin analogues for the treatment of neurodegenerative disorders
ZA200903242B (en) Treatment for multiple myeloma
AP2010005225A0 (en) Process for treating sulphatecontaining effluent